Purchase Order 75F40120P00325
Award Date 7/6/20
Potential Completion Date 11/6/20
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Athens, GA 30601, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a definitive firm fixed-price contract valued at $358,686.73 to S-3 Research LLC, a San Diego-based minority-owned small disadvantaged business specializing in data science and machine learning applications. Under this contract, S-3 Research will acquire access to data and services to better understand consumers and potential health risks associated with cannabis-derived products. The contract, awarded on February 10, 2023, with an ultimate completion...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $142,172.05 delivery order contract to Federal Resources Supply Company, LLC (doing business as Federal Resources) for the provision of one portable gas chromatograph with mass spectral detection system (GC-MS). This contract supports the FDA's mission to protect public health through the rapid screening of drug products and dietary supplements. The contract is a firm fixed-price delivery order...
- The Department of Health and Human Services National Institutes of Health National Center for Complementary and Integrative Health (NCCIH) awarded a firm fixed price purchase order to Steven W Gust, a for-profit organization, to provide part-time consultant services to the NCCIH Cannabinoid Working Group. The period of performance is from August 15, 2022 through August 14, 2024, with a potential value of $95,943.00. This award was not set aside for any specific business type. The original...
- The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
- The Food and Drug Administration (FDA) awarded a $840,181.30 definitive contract to Brightfield Group LLC, a for-profit organization, for online data subscription and specialized analytic services. The contract, which runs from July 2021 to February 2025, is a firm fixed-price agreement with no set-aside designation. Through this contract, Brightfield Group will provide exploratory behavioral economics studies, data subscriptions, and analytical support to aid the FDA's regulatory and public...
- This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $193,355.34 firm fixed-price delivery order contract to Goldbelt C6, LLC, an Alaska Native Corporation-owned small disadvantaged business, for the development of a physiologically-based pharmacokinetic (PBPK) model for per- and polyfluoroalkyl substances (PFAS). This order is part of larger indefinite delivery/indefinite quantity (IDIQ) contracts Goldbelt C6 holds with the FDA and other federal...
- The U.S. Food and Drug Administration (FDA) awarded a $24,585 firm-fixed-price purchase order to Orange Photonics, Inc., a for-profit manufacturer of goods, for the provision of cannabis analyzers and related services. This contract has a completion date of July 31, 2023 and does not have a set-aside designation. Orange Photonics, Inc. has received multiple federal contracts from agencies such as the Department of Homeland Security (DHS) Customs and Border Protection, Immigration and Customs...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...